Evan Lippman
Corporate Officer/Principal bei ALNYLAM PHARMACEUTICALS, INC.
Aktive Positionen von Evan Lippman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21.09.2022 | - |
Karriereverlauf von Evan Lippman
Ehemalige bekannte Positionen von Evan Lippman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AILERON THERAPEUTICS, INC. | Finanzdirektor/CFO | 08.01.2015 | 31.12.2016 |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Geschäftsführer | - | - |
Präsident | - | - | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 14.06.2012 | - |
Ausbildung von Evan Lippman
Bucknell University | Undergraduate Degree |
Georgia State University | Undergraduate Degree |
Cornell University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 2 |
Undergraduate Degree | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Health Technology |
- Börse
- Insiders
- Evan Lippman
- Erfahrung